Metraipolis › archive › dc_f2eb7d7a3379
Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of… — Europe PMC PMID:41827460
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41827460
- DOI
- 10.3390/jcm15052044
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T00:54:51.153Z
- SHA-256 of the archived text
f9cd8473965ea8bf951e5d5df19ddb289bc3238eab0fc7abc587474b0c259cc5- Stable URL of this page
https://metraipolis.com/documento/dc_f2eb7d7a3379
How to cite
Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of… — Europe PMC PMID:41827460 — Europe PMC (en), https://europepmc.org/article/MED/41827460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2eb7d7a3379 (Metraipolis archive dc_f2eb7d7a3379, sha256 f9cd8473965ea8bf951e5d5df19ddb289bc3238eab0fc7abc587474b0c259cc5)
BibTeX
@misc{dcf2eb7d7a3379,
title = {Avatrombopag Reduces Platelet Transfusion Requirement in Thrombocytopenia Subsequent to Antineoplastic Therapies in Haematological Patients: The Experience of… — Europe PMC PMID:41827460},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41827460},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2eb7d7a3379; sha256 f9cd8473965ea8bf951e5d5df19ddb289bc3238eab0fc7abc587474b0c259cc5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827460. Agents can read the archived copy with the MCP tool read_document.